The Oncology Institute to Participate in the 25th Annual Needham Healthcare Conference
Rhea-AI Summary
The Oncology Institute (NASDAQ: TOI) announced that CEO Dr. Daniel Virnich and CFO Rob Carter will participate in the 25th Annual Needham Healthcare Conference on Wednesday, April 15, 2026, including a fireside chat at 3:45 p.m. ET.
A live webcast of the presentation will be accessible via the company's Investor Relations website.
Positive
- None.
Negative
- None.
News Market Reaction – TOIIW
In the Apr 9 session, TOIIW declined 1.89%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Apr 06 | Executive appointment | Positive | +15.8% | Named a new Chief Legal Officer to oversee legal and compliance functions. |
| Mar 12 | Earnings and guidance | Positive | +107.7% | Reported strong 2025 revenue growth and issued detailed 2026 guidance. |
| Feb 26 | Earnings call notice | Neutral | +12.4% | Announced timing and access details for Q4 and full-year 2025 results call. |
| Feb 25 | Conference participation | Positive | +6.4% | Outlined management participation in multiple March healthcare investor conferences. |
| Feb 23 | Board appointment | Positive | +0.0% | Appointed an experienced healthcare executive to the Board of Directors. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent corporate, earnings, and conference-related announcements often coincided with positive or sharply higher next-day moves, suggesting the name has been sensitive to news flow.
Over the last few months, The Oncology Institute has reported strong growth with Q4 2025 and full-year 2025 results that drove a 107.69% move, while guidance framed a path toward improved profitability. Board and executive appointments on Feb 23, 2026 and Apr 6, 2026 focused on governance and legal capabilities. Multiple investor conference appearances in March 2026 also aligned with gains. Today’s Needham conference participation continues this pattern of active investor engagement and corporate visibility.
AI-generated analysis. How Rhea-AI works. Not financial advice.
CERRITOS, Calif., April 09, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that Dr. Daniel Virnich, Chief Executive Officer, and Rob Carter, Chief Financial Officer, will participate in the 25th Annual Needham Healthcare Conference, being held virtually on Wednesday, April 15, 2026, including a fireside chat at 3:45 p.m. ET.
A webcast link of the presentation will be accessible through the Investor Relations section of the Company’s website at https://investors.theoncologyinstitute.com/.
About The Oncology Institute (www.theoncologyinstitute.com):
Founded in 2007, The Oncology Institute (NASDAQ: TOI) is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of approximately 1.9 million patients, including clinical trials, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With over 180 employed and affiliate clinicians and over 100 clinics and affiliate locations of care across five states and growing, TOI is changing oncology for the better.
Media
The Oncology Institute, Inc.
marketing@theoncologyinstitute.com
Investors
ICR Healthcare
TOI@icrhealthcare.com
